loading

Bridgebio Pharma Inc 주식(BBIO)의 최신 뉴스

pulisher
Jun 18, 2025

10 Biotech Stocks Screaming a Buy - Insider Monkey

Jun 18, 2025
pulisher
Jun 17, 2025

Wolfe Research Initiates Coverage on BBIO with Outperform Rating - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Wolfe Research Initiates Coverage on BBIO with Outperform Rating | BBIO Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

BridgeBio (BBIO) Gains Positive Outlook with Strong Transthyreti - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Wolfe Research Initiates Coverage on BridgeBio Pharma With Outperform Rating, $49 Price Target - MarketScreener

Jun 17, 2025
pulisher
Jun 16, 2025

BridgeBio (BBIO) Receives Outperform Rating from Wolfe Research | BBIO Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

BridgeBio Pharma stock reaches 52-week high at $40.45 By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 16, 2025

BridgeBio Pharma stock reaches 52-week high at $40.45 - Investing.com

Jun 16, 2025
pulisher
Jun 14, 2025

BridgeBio Pharma, Inc. (BBIO) Price Target Raised to $56 from $53 at H.C. Wainwright - MSN

Jun 14, 2025
pulisher
Jun 14, 2025

BridgeBio Pharma’s SWOT analysis: stock poised for growth amid challenges - Investing.com

Jun 14, 2025
pulisher
Jun 12, 2025

When the Price of (BBIO) Talks, People Listen - news.stocktradersdaily.com

Jun 12, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Comments on BBIO FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

13 Biotech Stocks with Huge Upside Potential - Insider Monkey

Jun 11, 2025
pulisher
Jun 10, 2025

BridgeBio Pharma (NASDAQ:BBIO) Given New $56.00 Price Target at HC Wainwright - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Day 8 of Gains Streak for BridgeBio Pharma Stock with 21% Return (vs. 42% YTD) [6/9/2025] - Trefis

Jun 10, 2025
pulisher
Jun 09, 2025

BridgeBio stock holds Buy rating, price target at $56H.C. Wainwright - Investing.com Canada

Jun 09, 2025
pulisher
Jun 09, 2025

BridgeBio Pharma (BBIO) Sees Price Target Increase by HC Wainwri - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

BridgeBio (BBIO) Price Target Raised to $56 by H.C. Wainwright | - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Transcript : BridgeBio Pharma, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

BridgeBio Pharma (BBIO) Sees Price Target Increase by HC Wainwright & Co. | BBIO Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

BridgeBio (BBIO) Price Target Raised to $56 by H.C. Wainwright | BBIO Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Breakthrough Growth in Transthyretin Amyloid Cardiomyopathy - openPR.com

Jun 09, 2025
pulisher
Jun 07, 2025

Why BridgeBio Pharma, Inc. (BBIO) Surged on Wednesday - MSN

Jun 07, 2025
pulisher
Jun 06, 2025

BridgeBio Pharma stock hits 52-week high at $39.58 By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

BridgeBio Pharma stock hits 52-week high at $39.58 - Investing.com Australia

Jun 06, 2025
pulisher
Jun 06, 2025

BMO Maintains Hold on BridgeBio (BBIO) Amid Intensifying Competition - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

Piper Sandler maintains overweight rating on BridgeBio Pharma stock - Investing.com

Jun 06, 2025
pulisher
Jun 06, 2025

Piper Sandler maintains overweight rating on BridgeBio Pharma stock By Investing.com - Investing.com UK

Jun 06, 2025
pulisher
Jun 05, 2025

BridgeBio Pharma doses first asymptomatic subject in study of ATTR prevention drug - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

BridgeBio price target raised to $42 from $37 at BMO Capital - Yahoo Finance

Jun 05, 2025
pulisher
Jun 04, 2025

BMO Capital raises BridgeBio Pharma stock price target to $42 By Investing.com - Investing.com UK

Jun 04, 2025
pulisher
Jun 04, 2025

BridgeBio (BBIO) Target Price Raised by BMO Capital | BBIO Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Exploring High Growth Tech Stocks In The US Market - simplywall.st

Jun 04, 2025
pulisher
Jun 04, 2025

BridgeBio: New Data Bolsters The Bull Case (NASDAQ:BBIO) - Seeking Alpha

Jun 04, 2025
pulisher
Jun 02, 2025

BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 | BBIO Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

BridgeBio Management Reveals Latest Genetic Disease Strategy at Goldman Sachs Healthcare Conference 2025 - Stock Titan

Jun 02, 2025
pulisher
Jun 01, 2025

BridgeBio Pharma (NASDAQ:BBIO) Rating Lowered to “Sell” at Wall Street Zen - Defense World

Jun 01, 2025
pulisher
May 28, 2025

Nuveen Asset Management LLC Cuts Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO) - Defense World

May 28, 2025
pulisher
May 27, 2025

Possible Bearish Signals With BridgeBio Pharma Insiders Disposing Stock - simplywall.st

May 27, 2025
pulisher
May 26, 2025

BridgeBio Pharma’s SWOT analysis: stock soars on Attruby success, pipeline potential - Investing.com Nigeria

May 26, 2025
pulisher
May 26, 2025

Propionic Acidemia Market Statistics Expected to Experience Major Growth by 2034, According to DelveInsight | Bridge Bio Pharma, HemoShear Therapeutics, Moderna Therapeutics - Barchart.com

May 26, 2025
pulisher
May 24, 2025

Cetera Investment Advisers Takes $1.02 Million Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO) - Defense World

May 24, 2025
pulisher
May 21, 2025

The Play On BridgeBio Pharma: Great Expectations For Attruby (NASDAQ:BBIO) - Seeking Alpha

May 21, 2025
pulisher
May 21, 2025

BridgeBio’s Acoramidis: A Breakthrough in ATTR-CM Treatment - Insider Monkey

May 21, 2025
pulisher
May 21, 2025

Trading (BBIO) With Integrated Risk Controls - news.stocktradersdaily.com

May 21, 2025
pulisher
May 20, 2025

Acoramidis Reduced Incidence of Atrial Fibrillation Events in Patients with ATTR-CM - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

BridgeBio (BBIO) Shares Positive Phase 3 Study Data | BBIO Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Acoramidis Reduced Incidence of Atrial Fibrillation Events in Patients with ATTR-CM | BBIO Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Breakthrough: New ATTR-CM Treatment Cuts Heart Complications by 43%, Shows Fastest Clinical Benefits Ever - Stock Titan

May 20, 2025
pulisher
May 19, 2025

BridgeBio’s acoramidis shows promise in ATTR-CM study By Investing.com - Investing.com Nigeria

May 19, 2025
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
자본화:     |  볼륨(24시간):